Granules, Laurus Labs to invest Rs 700 crores for setting up Greenfield facilities
Rama Rao thanked the leadership of both the companies for choosing to invest in Telangana and said the state government would provide all possible support to them.;
Advertisement
Hyderabad: Two city-based pharma companies- Granules India and Laurus Labs on Tuesday separately announced major investments in Genome Valley here.
Granules India said it would be setting up a facility with a capacity to manufacture 10 billion units of finished dosages at an investment of Rs 400 crore The proposed unit would generate employment for about 1,600 people, an official release from Industries Minister K T Rama Raos office said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.